Media

DSM Foundation responds to Tobacco and Vapes Bill completing its passage through parliament

The DSM Foundation is pleased to see that the Tobacco and Vapes Bill has completed its passage through parliament. With media sources stating that the Bill will receive Royal Assent before the end of April 2026 – becoming legislation in the form of the Tobacco and Vapes Act 2026 – this will mean the significant […]

DSM Foundation responds to Tobacco and Vapes Bill completing its passage through parliament Read More »

DSM Foundation response to the ACMD’s updated review of ketamine use and harms

Recent significant rises in the use of ketamine by young people, and in the harms it can cause – in particular in relation to bladder damage, dependence, and drug-related deaths – have led to growing concerns for drug education charity the DSM Foundation. In their student surveys, ketamine is consistently perceived as the most prevalent substance being used by 15-18 year olds, after alcohol, nicotine and cannabis, overtaking others such as cocaine and MDMA, and this has

DSM Foundation response to the ACMD’s updated review of ketamine use and harms Read More »

DSM Foundation responds to ASH’s annual survey on youth vaping in Great Britain

The DSM Foundation, a charity dedicated to drug education, has welcomed new data released by Action on Smoking and Health (ASH) showing stability in vaping rates among young people aged 11–17 in Great Britain. However, the charity echoes ASH’s concern over a significant increase in those identifying as “ever smokers,” rising from 14% in 2023

DSM Foundation responds to ASH’s annual survey on youth vaping in Great Britain Read More »

DSM Foundation responds to disposable vape ban with its unique insights on young people and drugs

Ten days on from the UK-wide ban on disposable vapes that was introduced on June 1, drug education charity the DSM Foundation is commenting on how they see this impacting young people in particular – who have, in the past, been cited as the biggest users of single use vapes. Although it is likely to

DSM Foundation responds to disposable vape ban with its unique insights on young people and drugs Read More »

1,000 performances of ‘I Love You, Mum – I Promise I Won’t Die’

The DSM Foundation is proud to announce the 1,000th performance of the play that tells the story of Daniel Spargo-Mabbs, for whom the drugs education charity is named. Commissioned shortly after Dan died from an accidental overdose of ecstasy in 2014, ‘I Love You, Mum – I Promise I Won’t Die’ bears the title of

1,000 performances of ‘I Love You, Mum – I Promise I Won’t Die’ Read More »

DSM Foundation student survey reveals that nearly half of 15-18 year olds say nicotine pouches are around for them and their peers

Survey data from over 2,100 15-18 year olds gathered by drug education charity the DSM Foundation has shown that 46 per cent of respondents say that nicotine pouches – often referred to as “snus” – are one of the main substances used by their peers. This survey was the first in which nicotine pouches were

DSM Foundation student survey reveals that nearly half of 15-18 year olds say nicotine pouches are around for them and their peers Read More »

DSM Foundation welcomes government move to try and deal with issues being posed by xylazine and nitazenes

Drugs education charity the DSM Foundation has welcomed the Government’s announcement of steps to combat the threat posed by synthetic drugs such as nitazenes (strong laboratory-manufactured opioids) and xylazine (a veterinary sedative). DSM Foundation Director and Founder mum Fiona Spargo-Mabbs OBE said: “”As a charity founded in response to the loss of a young life

DSM Foundation welcomes government move to try and deal with issues being posed by xylazine and nitazenes Read More »

Fiona Spargo-Mabbs appointed to government drugs advisory body

The DSM Foundation is delighted to announce that drugs education charity founder and director Fiona Spargo-Mabbs OBE has been appointed to the Advisory Council on the Misuse of Drugs. The ACMD is an advisory non-departmental public body that makes recommendations to the government on the control of dangerous or otherwise harmful drugs, including classification and

Fiona Spargo-Mabbs appointed to government drugs advisory body Read More »

DSM Foundation responds to government moves to reclassify ketamine as a Class A substance

The government has announced plans to seek advice on ketamine, including consideration of whether it should remain a Class B substance under the Misuse of Drugs Act 10971 or move to Class A, the most tightly regulated group. The BBC – among other media outlets – has covered this news at https://www.bbc.co.uk/news/articles/cp8306prgy6o DSM Foundation Director,

DSM Foundation responds to government moves to reclassify ketamine as a Class A substance Read More »